Literature DB >> 8866403

Hypertension may be transplanted with the kidney in humans: a long-term historical prospective follow-up of recipients grafted with kidneys coming from donors with or without hypertension in their families.

E Guidi1, D Menghetti, S Milani, G Montagnino, P Palazzi, G Bianchi.   

Abstract

In several genetic hypertensive rat strains, transplantation studies have established that the kidney carries at least a portion of the genetic message for hypertension. In man it has, of course, been more difficult to obtain clearcut results. This historical prospective observational study, double-blinded for knowledge of donors' and recipients' family history for hypertension, concerns 85 transplanted patients, not treated with cyclosporine and with stable renal function, followed up for an average of 8 yr. Both the donors' and the recipients' families were carefully characterized for presence or absence of hypertension. After transplantation, in recipients without hypertension in their own families, a kidney coming from a "hypertensive" family determines less withdrawal and more introduction of antihypertensive therapy (AHT) than a kidney from a "normotensive" family (odds ratio for AHT introduction 5.0, confidence interval, 1.4 to 17.8; P = 0.017). In recipients with familial hypertension, the origin of the kidney does not influence the prevalence of hypertension after transplantation. More detailed analyses show that, in recipients without familial hypertension, the transplantation of a "hypertensive" kidney determines a tenfold larger increase in the requirement of antihypertensive therapy than the transplantation of a "normotensive" kidney, to obtain a similar blood pressure control (P = 0.003). This results is confirmed by the analysis of time-profile trends for antihypertensive therapy, adjusted for missing data, in the most clinically stable period (2nd to 10th yr after transplantation). The transmission of familial hypertension with the kidney is thus seen only in recipients coming from "normotensive" families, because a familial tendency for hypertension blunts the effect of receiving a "hypertensive" kidney.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8866403     DOI: 10.1681/ASN.V781131

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  18 in total

1.  Counterpoint: Activation of the intrarenal renin-angiotensin system is the dominant contributor to systemic hypertension.

Authors:  L Gabriel Navar
Journal:  J Appl Physiol (1985)       Date:  2010-12

Review 2.  Personalized Therapy of Hypertension: the Past and the Future.

Authors:  Paolo Manunta; Mara Ferrandi; Daniele Cusi; Patrizia Ferrari; Jan Staessen; Giuseppe Bianchi
Journal:  Curr Hypertens Rep       Date:  2016-03       Impact factor: 5.369

3.  Use of ambulatory blood pressure monitoring in kidney transplant recipients.

Authors:  Adrian M Whelan; Elaine Ku
Journal:  Nephrol Dial Transplant       Date:  2019-09-01       Impact factor: 5.992

Review 4.  The role of the kidney in regulating arterial blood pressure.

Authors:  Hani M Wadei; Stephen C Textor
Journal:  Nat Rev Nephrol       Date:  2012-08-28       Impact factor: 28.314

5.  Renal Dysfunction, Rather Than Nonrenal Vascular Dysfunction, Mediates Salt-Induced Hypertension.

Authors:  John E Hall
Journal:  Circulation       Date:  2016-03-01       Impact factor: 29.690

Review 6.  Signaling mechanisms that link salt retention to hypertension: endogenous ouabain, the Na(+) pump, the Na(+)/Ca(2+) exchanger and TRPC proteins.

Authors:  Mordecai P Blaustein; John M Hamlyn
Journal:  Biochim Biophys Acta       Date:  2010-03-06

Review 7.  Hypertension and the kidney.

Authors:  D E Wesson
Journal:  Curr Hypertens Rep       Date:  2001-12       Impact factor: 5.369

8.  Role of Kidneys in Sex Differences in Angiotensin II-Induced Hypertension.

Authors:  Lei Wang; Ximing Wang; Helena Y Qu; Shan Jiang; Jie Zhang; Liying Fu; Jacentha Buggs; Bo Pang; Jin Wei; Ruisheng Liu
Journal:  Hypertension       Date:  2017-10-23       Impact factor: 10.190

Review 9.  The Evaluation and Therapeutic Management of Hypertension in the Transplant Patient.

Authors:  Beje Thomas; Matthew R Weir
Journal:  Curr Cardiol Rep       Date:  2015-11       Impact factor: 2.931

Review 10.  Hypertension in patients with chronic kidney disease.

Authors:  Ranjan Chanda; Andrew Z Fenves
Journal:  Curr Hypertens Rep       Date:  2009-10       Impact factor: 5.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.